Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of I-131 dosing with or without lithium carbonate in rapid turnover Graves' disease
TCTR20151023001Phase 4Enrolling by invitation
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Apr 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Phase 4 trial of iodine-131 and lithium carbonate in Graves' disease (3 arms), sponsored by Ratchadaphiseksomphot Endowment Fund. Started Apr 2015; status: enrolling by invitation.
02
Drugs
iodine-131lithium carbonate
03
Conditions
Graves' disease
Beyond the preview
Go deeper on TCTR20151023001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20151023001.